NRI.to - TO WATCH

Monday, we will know the FDA's decision regarding the marketing of Piaglis the United States. This decision should affect the stock price that has stabilized at a price of $ 0.13 for some days. The company is well positioned to see its share price rise with the recent news made ​​Thursday by the directions, which shows a large increase in sales due to the problem of pensaid voltaren. Moreover, with a positive decision from the FDA position and future financial results of the first quarter due out around May or June, the company is well positioned to me that one way for hisshare price continue to grow.